NSE: SMSPHARMA | BSE: 532815

Strong Performer, Getting Expensive

Download real time

244.28 8.03 (3.40%)

38.62% Fall from 52W High

268.8K NSE+BSE Volume

NSE 08 Sep, 2025 3:31 PM (IST)

2,165.6

Market Cap

Above industry Median

1.3

Beta 1Year

Very High Volatility

Dividend

SMS Pharmaceuticals Ltd. has an upcoming dividend of ₹0.40 per share due on 22 Sep 2025 See details

SMS Pharmaceuticals Ltd. share price target and research reports

Name: Latest research reports of SMS Pharmaceuticals Ltd. authored by Karvy and published by - Trendlyne research reports.
Item: SMS Pharmaceuticals Ltd.
Rating: 3
Author: Karvy

Latest analyst research reports with target prices and PDF download for SMSPHARMA, BSE:532815 SMS Pharmaceuticals Ltd.

Search Inside the pdf :

SMS Pharmaceuticals Ltd.

04 Mar 2025

244.28

3.40%

SMS Pharmaceuticals | Plant Visit Note

Not Rated: SMS Pharmaceuticals Ltd.

Edelweiss

Ibuprofen to accelerate growth

SMS Pharmaceuticals Ltd. has gained 22.81% in the last 6 Months

SMS Pharmaceuticals Ltd.

09 Jul 2015, 12:00AM

244.28

3.40%

SMS Pharmaceuticals Ltd: Stable Stage Post Volatility; Future Plans to Unfold (Jul 09, 2015)

Hold: SMS Pharmaceuticals Ltd.

Karvy

Scaled up base portfolio: The company has a base portfolio in long standingGastrointestinal and Antimigraine accounting for close to 40% of existing portfolio.Operating in such long standing therapies, the company delivered Rs. 5000 Mn inrevenues in FY14 (111% YoY) and sustained the scale with 12% growth in FY15.

SMS Pharmaceuticals Ltd. has gained 22.81% in the last 6 Months

Is SMS Pharmaceuticals Ltd. worth buying?

80 Votes:

Buy 86.25%

Sell 10.0%

Hold 3.75%

RESEARCH REPORTS

Not Rated SEE REPORTS >

pdf link

Hold SEE REPORTS >

pdf